(Q74578250)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9597194%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

review article

1 reference

title

The use of aspirin in polycythaemia vera and primary thrombocythaemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9597194%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

S Willoughby

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9597194%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

T C Pearson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9597194%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 March 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9597194%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9597194%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9597194%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9597194%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

12-22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9597194%20AND%20SRC:MED&resulttype=core&format=json

Complications and causes of death in polycythaemia vera

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Prevention and treatment of thrombotic complications in essential thrombocythaemia: efficacy and safety of aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

The arterial complications of polycythaemia vera

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Treatment of primary proliferative polycythaemia by venesection and low dose busulphan: retrospective study from one centre

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Primary thrombocythaemia: diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Polycythemia vera: the natural history of 1213 patients followed for 20 years. Gruppo Italiano Studio Policitemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Treatment strategies in essential thrombocythemia. A critical appraisal of various experiences in different centers

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Vascular occlusive episodes and venous haematocrit in primary proliferative polycythaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Thrombotic and hemorrhagic complications in essential thrombocythemia. A retrospective study of 103 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Atypical transient ischemic attacks in thrombocythemia of various myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

The Management of Polycythaemia Vera

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Life-threatening thrombotic and haemorrhagic problems associated with silent myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

The course and complications of idiopathic erythrocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Polycythaemia and thrombocythaemia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

The myeloproliferative disorders. An historical appraisal and personal experiences

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Transient neurologic and ocular manifestations in primary thrombocythemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Erythromelalgia and arterial thrombophilia in thrombocythemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Erythromelalgic, thrombotic and hemorrhagic manifestations in 50 cases of thrombocythemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Neurologic and visual symptoms in essential thrombocythemia: efficacy of low-dose aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

SURGERY IN POLYCYTHEMIA VERA.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Blood platelet count and function are related to total and cardiovascular death in apparently healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Myeloproliferative disorders: a paradox of in-vivo and in-vitro platelet function

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Histopathology of erythromelalgia in thrombocythaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Erythromelalgia: a pathognomonic microvascular thrombotic complication in essential thrombocythemia and polycythemia vera

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Hemorheologic considerations in the pathogenesis of vascular occlusive events in polycythemia vera

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Aspirin as an antiplatelet drug

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Platelet suppressive therapy in clinical medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Aspirin and other platelet-active drugs. The relationship among dose, effectiveness, and side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Influence of aspirin on human megakaryocyte prostaglandin synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Aspirin in polycythemia vera and essential thrombocythemia: current facts and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Thrombocytosis, circulating platelet aggregates, and neurological dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Aspirin, prostaglandins, and peripheral gangrene

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Endogenous platelet fibrinogen: its modulation after surface expression is related to size-selective access to and conformational changes in the bound fibrinogen

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Platelet activation and thrombosis: studies in a patient with essential thrombocythemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Prostaglandin cyclooxygenase products but not thromboxane A(2) are involved in the pathogenesis of ewthromelalgia in thrombocythaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Primary thrombocythaemia in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Essential thrombocythemia and pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Primary thrombocythemia and pregnancy: treatment and outcome in fifteen cases

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Postpartum thrombosis in primary thrombocythaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Acquired von Willebrand disease in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Bleeding time and platelet function in essential thrombocythemia and other myeloproliferative syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

The reduction of large von Willebrand factor multimers in plasma in essential thrombocythaemia is related to the platelet count

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Aspirin and the stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Prophylactic aspirin and risk of peptic ulcer bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Low-dose aspirin in polycythaemia vera: a pilot study. Gruppo Italiano Studio Policitemia (GISP)

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Aspirin sensitivity. A distressing reaction that is now often treatable

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

1 reference

7 January 2021

Antithrombotic treatment of cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Novel Antithrombotic Drugs in Development

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Novel antiplatelet therapies for treatment of patients with ischemic heart disease: inhibitors of the platelet glycoprotein IIb/IIIa integrin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

The very-long-term course of polycythaemia: a complement to the previously published data of the Polycythaemia Vera Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

Incidence of myelofibrosis following treatment of primary polycythaemia by venesection

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

The Management of Essential Thrombocythaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2898%2990026-1

7 January 2021

10.1016/S0268-960X(98)90026-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9597194%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference